Inventor
EUGENE R. HICKEY
Inventor
US
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations32%
C07DHeterocyclic compounds32%
A61KPreparations for medical, dental or toiletry purposes23%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium14%
PatentTitleYear
12,030,862Allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) for the treatment of disease202411,919,902Aryl-bipyridine amine derivatives as phosphatidylinositol phosphate kinase inhibitors202411,878,970Allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) for the treatment of disease202411,873,295Allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) for the treatment of disease202411,667,651Aminopyridine derivatives as phosphatidylinositol phosphate kinase inhibitors202311,649,227Allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) for the treatment of disease202311,584,763Chromenopyridine derivatives as phosphatidylinositol phosphate kinase inhibitors2023Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2023–2024Patents assigned to PETRA PHARMA CORP (4)· patent assignee history
2023–2024Patents assigned to HIBERCELL INC (3)· patent assignee history
2023–2024Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| PETRA PHARMA CORP | 4 | 2023–2024 |
| HIBERCELL INC | 3 | 2023–2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 7 | 2023–2024 |